Advertisement
UK markets open in 4 hours 45 minutes

  • NIKKEI 225

    38,360.67
    +158.30 (+0.41%)
     

  • HANG SENG

    18,449.94
    +136.08 (+0.74%)
     

  • CRUDE OIL

    79.31
    +0.32 (+0.41%)
     

  • GOLD FUTURES

    2,316.80
    -5.50 (-0.24%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • Bitcoin GBP

    49,197.27
    -957.09 (-1.91%)
     

  • CMC Crypto 200

    1,311.16
    +16.49 (+1.27%)
     

  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     

  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

Global Skin Allergy Therapeutics Market to Reach $3.9 Billion by 2027

ReportLinker
·12-min read

Abstract: - Global Skin Allergy Therapeutics Market to Reach $3. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Skin Allergy Therapeutics estimated at US$2.

New York, June 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Skin Allergy Therapeutics Industry" - https://www.reportlinker.com/p06032888/?utm_source=GNW
8 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.
- The U.S. Market is Estimated at $759.7 Million, While China is Forecast to Grow at 7.8% CAGR
- The Skin Allergy Therapeutics market in the U.S. is estimated at US$759.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$822.8 Million by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

- Select Competitors (Total 34 Featured) -

  • bioMerieux

  • Danaher Corporation

  • Hitachi Chemical Diagnostics

  • HOB Biotech Group

  • Hycor Biomedical

  • Lincoln Diagnostics

  • Omega Diagnostics

  • Siemens Healthcare

  • Stallergenes Greer

  • Thermo Fisher Scientific




Read the full report: https://www.reportlinker.com/p06032888/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Skin Allergy
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Skin Allergy Therapeutics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Skin Allergy
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 4: USA Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 5: USA Historic Review for Skin Allergy Therapeutics by
Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

CANADA
Table 6: Canada Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 7: Canada Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

JAPAN
Table 8: Japan Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 9: Japan Historic Review for Skin Allergy Therapeutics by
Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

CHINA
Table 10: China Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 11: China Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

EUROPE
Table 12: Europe Current & Future Analysis for Skin Allergy
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 13: Europe Historic Review for Skin Allergy Therapeutics
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 14: Europe 15-Year Perspective for Skin Allergy
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

FRANCE
Table 15: France Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 16: France Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

GERMANY
Table 17: Germany Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 18: Germany Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

ITALY
Table 19: Italy Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 20: Italy Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 22: UK Historic Review for Skin Allergy Therapeutics by
Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

SPAIN
Table 23: Spain Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 24: Spain Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

RUSSIA
Table 25: Russia Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 26: Russia Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

REST OF EUROPE
Table 27: Rest of Europe Current & Future Analysis for Skin
Allergy Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 28: Rest of Europe Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

ASIA-PACIFIC
Table 29: Asia-Pacific Current & Future Analysis for Skin
Allergy Therapeutics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 30: Asia-Pacific Historic Review for Skin Allergy
Therapeutics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 31: Asia-Pacific 15-Year Perspective for Skin Allergy
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

AUSTRALIA
Table 32: Australia Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 33: Australia Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

INDIA
Table 34: India Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: India Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

SOUTH KOREA
Table 36: South Korea Current & Future Analysis for Skin
Allergy Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 37: South Korea Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

REST OF ASIA-PACIFIC
Table 38: Rest of Asia-Pacific Current & Future Analysis for
Skin Allergy Therapeutics by Segment - Skin Allergy
Therapeutics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 39: Rest of Asia-Pacific Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

LATIN AMERICA
Table 40: Latin America Current & Future Analysis for Skin
Allergy Therapeutics by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 41: Latin America Historic Review for Skin Allergy
Therapeutics by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 42: Latin America 15-Year Perspective for Skin Allergy
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2020 & 2027

ARGENTINA
Table 43: Argentina Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: Argentina Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

BRAZIL
Table 45: Brazil Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 46: Brazil Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

MEXICO
Table 47: Mexico Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 48: Mexico Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

REST OF LATIN AMERICA
Table 49: Rest of Latin America Current & Future Analysis for
Skin Allergy Therapeutics by Segment - Skin Allergy
Therapeutics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: Rest of Latin America Historic Review for Skin
Allergy Therapeutics by Segment - Skin Allergy Therapeutics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

MIDDLE EAST
Table 51: Middle East Current & Future Analysis for Skin
Allergy Therapeutics by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 52: Middle East Historic Review for Skin Allergy
Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia,
UAE and Rest of Middle East Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 53: Middle East 15-Year Perspective for Skin Allergy
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets for Years 2012, 2020 & 2027

IRAN
Table 54: Iran Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 55: Iran Historic Review for Skin Allergy Therapeutics by
Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

ISRAEL
Table 56: Israel Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 57: Israel Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

SAUDI ARABIA
Table 58: Saudi Arabia Current & Future Analysis for Skin
Allergy Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 59: Saudi Arabia Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

UNITED ARAB EMIRATES
Table 60: UAE Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 61: UAE Historic Review for Skin Allergy Therapeutics by
Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

REST OF MIDDLE EAST
Table 62: Rest of Middle East Current & Future Analysis for
Skin Allergy Therapeutics by Segment - Skin Allergy
Therapeutics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 63: Rest of Middle East Historic Review for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

AFRICA
Table 64: Africa Current & Future Analysis for Skin Allergy
Therapeutics by Segment - Skin Allergy Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: Africa Historic Review for Skin Allergy Therapeutics
by Segment - Skin Allergy Therapeutics Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

IV. COMPETITION
Total Companies Profiled: 34
Read the full report: https://www.reportlinker.com/p06032888/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001